ACTIVE HALF-LIFE
12-36 hours
CLASSIFICATION
Peptide Hormone
ACNE
No
WATER RETENTION
No
HBR
No
HEPATOTOXICITY
No
AROMATIZATION
No
MANUFACTURER
Ferring
WAREHOUSE
International Warehouse 2
SUBSTANCE
Human Menopausal Gonadotropin
,
Introducing Menogon 75IU Injection, also known as hMG or Menotropin, a powerful solution designed to combat infertility in women. This specialized peptide hormone plays a crucial role in stimulating egg production in the ovaries, making it an essential treatment for those facing ovarian failure. Sourced from the urine of postmenopausal women, Menogon contains high levels of follicle-stimulating hormone (FSH), luteinizing hormone (LH), and other vital gonadotropins. Administered intramuscularly, it provides a direct approach to enhancing fertility.
As with any medication, potential side effects may occur. Users of Menogon 75IU Injection have reported headaches, mood fluctuations, fatigue, weight gain, localized swelling at the injection site, and breast tenderness or enlargement. A significant consideration is the risk of abdominal pain caused by ovarian hyperstimulation syndrome (OHSS), a condition arising from excessive egg production and swollen ovaries. Additionally, there's a possibility of unintended twin conception following treatment. Prior to commencing this medication, it?s essential to consult your healthcare provider about any existing medical conditions, such as:
- Allergies to menotropins or gonadotropins
- Vaginal bleeding
- Ovarian cysts
Dosage is customized to meet individual needs, ensuring tailored treatment for each patient. For maximum effectiveness, it?s advisable to time conception with intercourse within 12 to 36 hours post-injection of Menogon 75IU. If the initial treatment cycle does not yield the desired results, reassessing your approach is essential. Should ovulation not occur after three treatment cycles, consult your doctor to address any concerns regarding Menogon 75IU Injection.